Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Com… Read more
Novavax Inc (NVAX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.309x
Based on the latest financial reports, Novavax Inc (NVAX) has a cash flow conversion efficiency ratio of 0.309x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-39.48 Million) by net assets ($-127.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Novavax Inc - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how Novavax Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Novavax Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novavax Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Exide Industries Limited
NSE:EXIDEIND
|
0.096x |
|
Jiangsu Dingsheng New Material Joint-Stock Co Ltd
SHG:603876
|
0.012x |
|
Yelp Inc
NYSE:YELP
|
0.179x |
|
Guangzhou Friendship Group Co Ltd
SHE:000987
|
0.029x |
|
SCHNEIDER NATL.INC. CL.B
F:SNIA
|
N/A |
|
Talos Energy Inc
F:7T2
|
0.048x |
|
Kyland Technology Co Ltd
SHE:300353
|
-0.023x |
|
China Literature Limited
PINK:CHLLF
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Novavax Inc (1996–2025)
The table below shows the annual cash flow conversion efficiency of Novavax Inc from 1996 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-127.75 Million | $-244.63 Million | 1.915x | +1268.96% |
| 2024-12-31 | $-623.84 Million | $-87.26 Million | 0.140x | -85.95% |
| 2023-12-31 | $-716.93 Million | $-713.97 Million | 0.996x | +51.82% |
| 2022-12-31 | $-634.08 Million | $-415.94 Million | 0.656x | +171.43% |
| 2021-12-31 | $-351.67 Million | $322.95 Million | -0.918x | -1253.93% |
| 2020-12-31 | $627.21 Million | $-42.54 Million | -0.068x | -109.23% |
| 2019-12-31 | $-186.02 Million | $-136.62 Million | 0.734x | -33.27% |
| 2018-12-31 | $-167.94 Million | $-184.82 Million | 1.101x | -19.27% |
| 2017-12-31 | $-101.73 Million | $-138.70 Million | 1.363x | -97.04% |
| 2016-12-31 | $-5.55 Million | $-255.47 Million | 46.063x | +10791.80% |
| 2015-12-31 | $292.67 Million | $-126.09 Million | -0.431x | -47.62% |
| 2014-12-31 | $229.62 Million | $-67.01 Million | -0.292x | -30.77% |
| 2013-12-31 | $203.23 Million | $-45.36 Million | -0.223x | +1.76% |
| 2012-12-31 | $80.24 Million | $-18.23 Million | -0.227x | +48.23% |
| 2011-12-31 | $53.85 Million | $-23.63 Million | -0.439x | +21.13% |
| 2010-12-31 | $59.05 Million | $-32.85 Million | -0.556x | -26.19% |
| 2009-12-31 | $74.47 Million | $-32.83 Million | -0.441x | +17.50% |
| 2008-12-31 | $45.49 Million | $-24.31 Million | -0.534x | -26.03% |
| 2007-12-31 | $63.06 Million | $-26.74 Million | -0.424x | -169.14% |
| 2006-12-31 | $94.00 Million | $-14.81 Million | -0.158x | -34.67% |
| 2005-12-31 | $49.65 Million | $-5.81 Million | -0.117x | +87.06% |
| 2004-12-31 | $33.28 Million | $-30.10 Million | -0.904x | -85.26% |
| 2003-12-31 | $35.94 Million | $-17.55 Million | -0.488x | +81.29% |
| 2002-12-31 | $8.07 Million | $-21.07 Million | -2.609x | -1471.21% |
| 2001-12-31 | $27.49 Million | $-4.57 Million | -0.166x | +47.38% |
| 2000-12-31 | $31.82 Million | $-10.04 Million | -0.316x | +76.12% |
| 1999-12-31 | $2.80 Million | $-3.70 Million | -1.321x | -10.12% |
| 1998-12-31 | $3.00 Million | $-3.60 Million | -1.200x | -85.71% |
| 1997-12-31 | $6.50 Million | $-4.20 Million | -0.646x | +0.14% |
| 1996-12-31 | $5.10 Million | $-3.30 Million | -0.647x | -- |